Mg. Bouma et al., THE ANTIINFLAMMATORY POTENTIAL OF ADENOSINE IN ISCHEMIA-REPERFUSION INJURY - ESTABLISHED AND PUTATIVE BENEFICIAL ACTIONS OF A RETALIATORY METABOLITE, Shock, 8(5), 1997, pp. 313-320
The endogenous metabolite adenosine has been recognized as a protectiv
e agent in the setting of ischemia-reperfusion. Because the formation
of adenosine during ischemia is closely linked to ATP catabolism, and
its actions antagonize the deleterious metabolic and cardiovascular co
nsequences of ischemia, it has been named a ''retaliatory'' metabolite
. During recent years, however, the insight into its diverse scope of
anti-inflammatory actions has increased considerably. In this review,
the beneficial metabolic and cardiovascular actions of adenosine in is
chemia and reperfusion are briefly outlined, followed by an extensive
discussion of the established and putative anti-inflammatory actions o
f adenosine in the inflammatory response to ischemia and reperfusion.
It is demonstrated that adenosine interferes with activated neutrophil
function, neutrophil-endothelial adhesive interactions, the productio
n and release of various inflammatory mediators, the expression of adh
esion molecules, and that it activates cellular antioxidant defense sy
stems, thus providing protective effects at multiple levels in the pat
hogenesis of ischemia and reperfusion. Finally, several potential phar
macological strategies to enhance the ''natural defense mechanism'' pr
ovided by endogenous adenosine are presented.